drugset / Trial / NCT06696742
PD1 Inhibitors Combined With Clostridium Butyricum for Urothelial Carcinoma
RandomizedParallel-groupDouble-blindTreatment
Summary
This study intends to explore whether the combination of Clostridium butyricum can improve the current situation of poor anti-PD1 treatment effect in patients with bladder cancer.
Timeline
- Start
- 2024-02-01
- Primary completion
- 2029-02-01
- Completion
- 2029-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clostridium butyricum | Other / unclassified | 20 mg | — |
| Comparator | Cisplatin | Other / unclassified | 70 mg/m2 | — |
| Background | Gemcitabine | Small molecule | 1 g | — |